期刊文献+

IGFBP-3、ER、PR在子宫肌瘤中表达的研究 被引量:12

A Study about the Expression of IGFBP-3、ER and PR in Hysteromyoma
下载PDF
导出
摘要 目的探讨胰岛素样生长因子结合蛋白-3(IGFBP-3)、雌激素受体(ER)、孕激素受体(PR)与子宫肌瘤的关系。方法子宫肌瘤患者38例(肌瘤组),正常妇女32例(对照组),分别采用酶联免疫吸附法、化学发光免疫法检测血清IGFBP-3、雌激素(E2)、孕激素(P)浓度,用免疫组化法检测子宫肌瘤患者子宫肌层和子宫肌瘤组织中的IGFBP-3、ER、PR的表达。结果肌瘤组患者血清IGFBP-3浓度低于对照组(P<0.05),E2、P浓度两组差异无统计学意义(P>0.05);IGFBP-3在肌瘤组织中表达较肌层组织中表达减弱(P<0.05);ER、PR在肌瘤组织中表达较肌层组织中表达增强(P<0.05);IGFBP-3与ER表达变化趋势呈负相关(P<0.05);肌瘤组血清IGFBP-3浓度与IGFBP-3在子宫肌瘤组织中表达强度呈正相关(P<0.05)。结论子宫肌瘤患者血清及肌瘤组织中IGFBP-3水平均降低,ER、PR在肌瘤组织中表达较肌层组织中表达增强,推测IGFBP-3表达的下降、雌激素受体与孕激素受体水平的升高与子宫肌瘤的发生有关,调控IGFBP-3、ER、PR水平有可能成为子宫肌瘤病因学治疗的研究方向。 Objective To explore the relationship between insulin-like growth factor binding protein-3(IGFBP-3),estrogen receptor(ER),progesterone receptor(PR) and hysteromyoma.Methods The IGFBP-3,ER,PR in the serumof 38 patients with hysteromyoma and 32 healthy women were detected by enzyme linked immonosorbent assay(ELISA) and chemiluminescent immunoassays respectively,the expressions of IGFBP-3,ER and PR in leiomyomatissue and myometrium 38 patients with hysteromyoma after hysterectomy were detected by immunohistochemistry.Results The serum level of IGFBP-3 was significantly lower than that of healthy controls(P0.05),while the serum levels of ER and PR showed no difference.The IGFBP-3 expression in leiomyoma tissue was lower than that of myometrium(P0.05).However,the expression of ER and PR in leiomyoma were both significantly higher than that of myometrium(P0.05).There was a negative correlation between IGFBP-3 and ER in leiomyoma tissue(P0.05) and there wasa positive correlation between the concentration of IGFBP-3 in serum and its intensity of expression in leiomyoma tissue(P0.05).Conclusion Low expression of IGFBP-3 and the overexpression of ER and PR in hysteromyoma may becorrelated with the occurrence and development of hysteromyoma.Regulation of IGFBP-3,ER and PR may become the research direction of etiological treatment in hysteromyoma.
出处 《广西医学》 CAS 2011年第6期664-667,共4页 Guangxi Medical Journal
基金 广西医药卫生科学研究资助项目(Z2006003)
关键词 子宫肌瘤 胰岛素样生长因子 胰岛素样生长因子结合蛋白-3 雌激素受体 孕激素受体 Hysteromyoma Insulin-like growth factor Insulin-like growth factor binding protein-3 Estrogen receptor Progesterone receptor
  • 相关文献

参考文献13

二级参考文献54

  • 1黄小英,罗艳琳.68例子宫肌瘤手术前后护理体会[J].中外医疗,2008,27(16). 被引量:8
  • 2杨燕贤,黄碧珠,王美娟,李若荣.中西医结合治疗子宫肌瘤148例疗效观察[J].现代中西医结合杂志,2005,14(24):3233-3234. 被引量:7
  • 3Ghigo E, Arvat E, Gianotti L, et. al. Hypothalamic growth hormone -insulin - like growth factor - I axis across the human life span. J Pediatr Endocrinol Metab. 2000; 13 Suppl 61493 -502. 被引量:1
  • 4Veldhuis JD. Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender. Growth Horm IGF Res,1998,8 Suppl B:49 -59. 被引量:1
  • 5Shah N, Evans WS, Bowers CY. Oral. estradiol administration modulates continuous intravenous growth hormone (GH) -releasing peptide-2 -driven GH secretion in postmenopausal women. J Clin Endocrinol Metab ,2000,85 ( 8 ) :2649 - 2659. 被引量:1
  • 6Wu X, Sallinen K, Zhou S. Androgen excess contributes to altered growth hormone/insulin - like growth factor - 1 axis in nonobese women with polycystic ovary syndrome. Fertil Steril,2000,73(4) :730- 734. 被引量:1
  • 7Yilmaz MD, Hosal AS, Oguz H, et al. The effects of tonsillectomy and adenoidectomy on serum IGF - I and IGFBI?'3 levels in children. Laryngoscope ,2002,112 ( 5 ) :922 - 925. 被引量:1
  • 8Orio F Jr, Palomba S, Colao A,et al. GH release after GHRH plus arginine administration, in obese and overweight women with polycystic ovary syndrome. J Endocrinol Invest,2003,26 (2) : 117 - 122. 被引量:1
  • 9Laban C, Bustin SA, Jenkins PJ. The GH - IGF - I axis and breastcancer. Trends Endocrinol Metab,2003,14( 1 ) :28 - 34. 被引量:1
  • 10Bustin SA, Jenkins PJ. The growth hormone - insulin - like growthfactor-I axis and colorectal cancer. Trends Mol Med,2001,7 (10)..447 - 454. 被引量:1

共引文献348

同被引文献125

引证文献12

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部